Micro-determination of tobramycin in serum by high-performance liquid chromatography with ultraviolet detection. 1981

D M Barends, and C L Zwaan, and A Hulshoff

A procedure for the high-performance liquid chromatographic determination of tobramycin in serum is described using pre-column derivatisation with 1-fluoro-2,4-dinitrobenzene and subsequent chromatographic analysis on a reversed-phase column with ultraviolet detection. Gentamicin is used as the internal standard. The sensitivity is 0.5 mg/l with 50-microliters samples. Precision, expressed as the coefficient of variation, is 3% or better in the concentration range 0.5-16 mg/l. The absolute recovery of tobramycin is 41%. The analyses of serum samples obtained in an in vivo experiment correlated well with the results from a microbiological assay. The influence of variation of derivatisation conditions and the implications for the reliability of the internal standardisation were studied. The 2,4-dinitrophenyl tobramycin derivative was synthesized and its structure was proved to be the fully derivatized tobramycin. Side-products of the derivatisation reaction were isolated.

UI MeSH Term Description Entries
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D014031 Tobramycin An aminoglycoside, broad-spectrum antibiotic produced by Streptomyces tenebrarius. It is effective against gram-negative bacteria, especially the PSEUDOMONAS species. It is a 10% component of the antibiotic complex, NEBRAMYCIN, produced by the same species. Nebramycin Factor 6,Brulamycin,Nebcin,Nebicin,Obracin,Tobracin,Tobramycin Sulfate,Sulfate, Tobramycin

Related Publications

D M Barends, and C L Zwaan, and A Hulshoff
May 1980, Journal of chromatography,
D M Barends, and C L Zwaan, and A Hulshoff
September 1983, Journal of chromatography,
D M Barends, and C L Zwaan, and A Hulshoff
December 2001, Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao,
D M Barends, and C L Zwaan, and A Hulshoff
June 2010, Biomedical chromatography : BMC,
D M Barends, and C L Zwaan, and A Hulshoff
January 1987, Biomedica biochimica acta,
D M Barends, and C L Zwaan, and A Hulshoff
October 1985, Journal of pharmaceutical sciences,
D M Barends, and C L Zwaan, and A Hulshoff
October 1988, Journal of chromatography,
D M Barends, and C L Zwaan, and A Hulshoff
May 2017, Biomedical chromatography : BMC,
D M Barends, and C L Zwaan, and A Hulshoff
September 1990, Journal of chromatography,
D M Barends, and C L Zwaan, and A Hulshoff
January 1982, Journal of chromatography,
Copied contents to your clipboard!